*15 min delay on quotes.
For all Investor Inquiries:
investors@neutrisci.com
CORPORATE PROFILE
NeutriSci International Inc. (TSXV: NU) develops, markets, and distributes clinically-proven nutraceutical products in Canada. Its products include Neuenergy®, an energy chewable tablet designed to deliver enhanced focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a vast distribution network of retail and online channels. NeutriSci International Inc. is headquartered in Calgary, Canada with employees nationwide in Vancouver, Toronto, and Montreal.
Get updates on press releases directly from NeutriSci International! Subscribe to our mailing list now and be the first to know when we publish updates and new press releases.
NeutriSci International complies with Canada’s Anti-Spam Legislation (CASL) and will not spam or sell your information to third party groups.
(NetworkNewsWire, Feb 26, 2018)
(NetworkNewsWire, Jan 26, 2018)
(Stockhouse, Jan 09, 2018)
(BioTuesdays, Jan 08, 2018)
(NetworkNewsWire, Jan 08, 2018)
– Signing of definitive agreement expected in early Q2 – First orders expected in early Q3 Vancouver, British Columbia – March 25, 2019 – Neutrisci International Inc. (the [...]
Vancouver, British Columbia – February 26, 2019 – Neutrisci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]
Vancouver, British Columbia – December 6, 2018 – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) has entered into a memorandum of [...]
Vancouver, British Columbia – October 17, 2018 – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® [...]
Vancouver, British Columbia – October 11, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) is pleased to [...]
VANCOUVER, British Columbia – October 5, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) is pleased to [...]